✦ LIBER ✦

Supportive therapy with mistletoe extract in tumor patients – Results of four controlled pharmacoepidemiological cohort studies as basis for prospective studies

✍ Scribed by M. Werner; P.R. Bock; J. Hanisch; G. Stauder

Book ID: 113848923
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 71 KB
Volume: 18
Category: Article
ISSN: 0944-7113
DOI: 10.1016/j.phymed.2011.09.030

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Fermented mistletoe (Viscum album L.) ex

Fermented mistletoe (Viscum album L.) extracts as supportive treatment in cancer patients—Results of four controlled pharmaco-epidemiological cohort studies

✍ G. Stauder; P.R. Bock 📂 Article 📅 2010 🏛 Elsevier 🌐 English ⚖ 69 KB

Golimumab, a human anti–tumor necrosis f

Golimumab, a human anti–tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four–week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 135 KB 👁 1 views

Erratum: Golimumab, a human anti-tumor n

Erratum: Golimumab, a human anti-tumor necrosis factor α monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naive patients with active rheumatoid arthritis: Twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis

✍ Paul Emery; Roy M. Fleischmann; Larry W. Moreland; Elizabeth C. Hsia; Ingrid Str 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 38 KB 👁 1 views